XML 81 R49.htm IDEA: XBRL DOCUMENT v3.21.2
Intangible Assets and Goodwill (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Jun. 30, 2020
Dec. 31, 2021
Jun. 30, 2021
Jun. 30, 2020
Mar. 31, 2021
Intangible assets              
Contingent consideration impairment $ (300,000)   $ (10,000,000.0)   $ 33,500,000 $ (5,500,000)  
Total intangible assets, gross 7,637,700,000 $ 8,220,800,000     7,637,700,000    
Accumulated Amortization (5,252,700,000) (5,136,500,000)     (5,252,700,000)    
Intangible assets, net 2,385,000,000.0 3,084,300,000     2,385,000,000.0    
Amortization and impairment of acquired intangible assets 604,100,000   61,500,000   702,200,000 133,000,000.0  
Expected future amortization expense, 2019 (remaining three months) 110,000,000.0       110,000,000.0    
Expected future amortization expense, 2020 215,000,000.0       215,000,000.0    
Expected future amortization expense, 2021 215,000,000.0       215,000,000.0    
Expected future amortization expense, 2022 225,000,000.0       225,000,000.0    
Expected future amortization expense, 2023 220,000,000.0       220,000,000.0    
Expected future amortization expense, 2024 200,000,000.0       200,000,000.0    
Impairment of intangible assets         585,900,000 0  
Impairment of Intangible Assets (Excluding Goodwill)     0   0 $ 0  
Out-licensed patents              
Intangible assets              
Cost 7,394,300,000 7,394,300,000     7,394,300,000    
Net 2,141,600,000 2,257,800,000     2,141,600,000    
Accumulated Amortization (5,252,700,000) (5,136,500,000)     $ (5,252,700,000)    
Out-licensed patents | Minimum              
Intangible assets              
Estimated life, (in years)         13 years    
Out-licensed patents | Maximum              
Intangible assets              
Estimated life, (in years)         23 years    
Developed technology | Minimum              
Intangible assets              
Estimated life, (in years)         15 years    
Developed technology | Maximum              
Intangible assets              
Estimated life, (in years)         28 years    
Acquired and in-licensed rights and patents | Minimum              
Intangible assets              
Estimated life, (in years)         4 years    
Acquired and in-licensed rights and patents | Maximum              
Intangible assets              
Estimated life, (in years)         18 years    
In Process Research and Development              
Intangible assets              
Indefinite lived intangible assets useful life         Indefinite until commercialization    
Cost and Net 179,400,000 762,500,000     $ 179,400,000    
Accumulated Amortization 0 0     $ 0    
Trademarks and Trade Names              
Intangible assets              
Indefinite lived intangible assets useful life         Indefinite    
Cost and Net 64,000,000.0 64,000,000.0     $ 64,000,000.0    
Accumulated Amortization 0 0     0    
Vixotrigine              
Intangible assets              
Amortization and impairment of acquired intangible assets 44,300,000   $ 0        
TGN [Member] | In Process Research and Development              
Intangible assets              
Cost and Net 136,000,000.0       136,000,000.0    
BIIB111 | In Process Research and Development              
Intangible assets              
Cost and Net 15,000,000.0       15,000,000.0   $ 365,000,000.0
BIIB111 | Nightstar              
Intangible assets              
Impairment of intangible assets 350,000,000.0 $ 115,000,000.0     350,000,000.0    
BIIB112 | In Process Research and Development              
Intangible assets              
Cost and Net 28,400,000       28,400,000   $ 220,000,000.0
BIIB112 | Nightstar              
Intangible assets              
Impairment of intangible assets $ 191,600,000       $ 191,600,000    
BIIB111 and BIIB112 | Nightstar | Forecast              
Intangible assets              
Impairment of intangible assets       $ 30,000,000.0